Catalyst Event
DB Insurance Co Ltd (005830) · Earnings Release
From Akros SCHK HK-Korea Quality Factor Index (ASHKQLT)
5/15/2026, 12:00:00 AM
Q1 2026 earnings release on May 15, 2026, is scheduled. Analysts forecast a potential year-over-year decline in net profit based on April 2026 estimates, justifying a medium negative impact scheduled.
Korean Translation
2026년 5월 15일 2026년 1분기 실적 발표 예정됨. 2026년 4월 애널리스트들의 순이익 감소 전망이 중간 정도의 부정적 영향의 근거로 제시되며 예정됨.
Related Recent Events
China Nonferrous Mining Corp Ltd (1258) · Other
Ex-dividend date for the proposed final dividend of USD 0.041446 per share for the year ended December 31, 2025, scheduled for 2026-06-30. Dividend distributions typically result in a price impact of 1-5%.
6/30/2026, 12:00:00 AM
Huadian Power International Corp Ltd (1071) · Other
Record date (2026-06-05) for the final dividend of RMB 0.14 per share for the year ended December 31, 2025, scheduled. The H-share register will be closed from June 3 to June 5, 2026, and the dividend is scheduled to be paid on July 28, 2026. Low impact estimated as dividend yield is typically stable and already priced in.
6/5/2026, 12:00:00 AM
DB Insurance Co Ltd (005830) · Other
Issuance of up to KRW 600 billion in subordinated capital securities in June 2026 is scheduled. Capital base strengthening and debt refinancing justify a low neutral impact estimate scheduled.
6/1/2026, 12:00:00 AM
Hanmi Semiconductor Co Ltd (042700) · Earnings Release
Q1 2026 earnings release, with medium importance estimated due to expected volatility in semiconductor equipment stocks, is scheduled.
5/20/2026, 12:00:00 AM
ANTA Sports Products Limited (2020) · Other
Final dividend of HKD 1.08 per share for the year ended December 31, 2025, with an ex-dividend date of May 15, 2026, and a payment date of June 1, 2026. This is estimated to have a low price impact of approximately 1.2% based on the dividend yield, scheduled.
5/15/2026, 12:00:00 AM
Alteogen Inc (196170) · Other
A US patent board invalidated a key patent of competitor Halozyme on May 14, 2026, reducing legal risks for Alteogen's partner Merck and leading to a significant stock price increase.
5/14/2026, 12:00:00 AM